BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21094210)

  • 1. Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation.
    Ringman JM; Gylys KH; Medina LD; Fox M; Kepe V; Flores DL; Apostolova LG; Barrio JR; Small G; Silverman DH; Siu E; Cederbaum S; Hecimovic S; Malnar M; Chakraverty S; Goate AM; Bird TD; Leverenz JB
    Neurosci Lett; 2011 Jan; 487(3):287-92. PubMed ID: 21094210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characterization of a presenilin 1 mutation (F177S) in a family with very early-onset Alzheimer's disease in the third decade of life.
    Hausner L; Tschäpe JA; Schmitt HP; Hentschel F; Hartmann T; Frölich L
    Alzheimers Dement; 2014 Mar; 10(2):e27-39. PubMed ID: 23850332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.
    Thordardottir S; Rodriguez-Vieitez E; Almkvist O; Ferreira D; Saint-Aubert L; Kinhult-Ståhlbom A; Thonberg H; Schöll M; Westman E; Wall A; Eriksdotter M; Zetterberg H; Blennow K; Nordberg A; Graff C
    Alzheimers Res Ther; 2018 May; 10(1):45. PubMed ID: 29747683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Pathogenic PSEN1 Ala285Val Mutation Associated with Early-Onset Alzheimer's Disease.
    Vo VG; Pyun JM; Bagyinszky E; An SSA; Kim SY
    Curr Alzheimer Res; 2020; 17(5):438-445. PubMed ID: 32589559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease.
    Natelson Love M; Clark DG; Cochran JN; Den Beste KA; Geldmacher DS; Benzinger TL; Gordon BA; Morris JC; Bateman RJ; Roberson ED
    Neurobiol Aging; 2017 Jan; 49():216.e7-216.e13. PubMed ID: 27793474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSEN1 variants in Korean patients with clinically suspicious early-onset familial Alzheimer's disease.
    Kim YE; Cho H; Kim HJ; Na DL; Seo SW; Ki CS
    Sci Rep; 2020 Feb; 10(1):3480. PubMed ID: 32103039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel PSEN1 H163P mutation in a patient with early-onset Alzheimer's disease: clinical, neuroimaging, and neuropathological findings.
    Kim J; Bagyinszky E; Chang YH; Choe G; Choi BO; An SS; Kim S
    Neurosci Lett; 2012 Nov; 530(2):109-14. PubMed ID: 23046926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 ratio.
    Qiu Q; Shen L; Jia L; Wang Q; Li F; Li Y; Jia J
    J Alzheimers Dis; 2019; 69(1):199-212. PubMed ID: 30958370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Presenilin 1 Mutation in Early-Onset Alzheimer's Disease With Prominent Frontal Features.
    Nygaard HB; Lippa CF; Mehdi D; Baehring JM
    Am J Alzheimers Dis Other Demen; 2014 Aug; 29(5):433-5. PubMed ID: 24463146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease.
    Liu CY; Ohki Y; Tomita T; Osawa S; Reed BR; Jagust W; Van Berlo V; Jin LW; Chui HC; Coppola G; Ringman JM
    J Alzheimers Dis; 2017; 58(4):1035-1041. PubMed ID: 28550247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
    Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
    Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism.
    Ringman JM; Casado M; Van Berlo V; Pa J; Joseph-Mathurin N; Fagan AM; Benzinger T; Bateman RJ; Morris JC
    Neurosci Lett; 2017 Sep; 657():11-15. PubMed ID: 28764909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
    Balasa M; Vidal-Piñeiro D; Lladó A; Antonell A; Bosch B; Castellanos F; Bargalló N; Bartres-Faz D; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the PSEN1 gene (L286P) associated with familial early-onset dementia of Alzheimer type and lobar haematomas.
    Sánchez-Valle R; Lladó A; Ezquerra M; Rey MJ; Rami L; Molinuevo JL
    Eur J Neurol; 2007 Dec; 14(12):1409-12. PubMed ID: 18028191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer's disease.
    Antonell A; Balasa M; Oliva R; Lladó A; Bosch B; Fabregat N; Fortea J; Molinuevo JL; Sánchez-Valle R
    Neurosci Lett; 2011 May; 496(1):40-2. PubMed ID: 21501661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers.
    Schöll M; Almkvist O; Bogdanovic N; Wall A; Långström B; Viitanen M; Nordberg A
    J Alzheimers Dis; 2011; 24(3):495-506. PubMed ID: 21297272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation.
    Kauwe JS; Jacquart S; Chakraverty S; Wang J; Mayo K; Fagan AM; Holtzman DM; Morris JC; Goate AM
    Ann Neurol; 2007 May; 61(5):446-53. PubMed ID: 17366635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A presenilin 1 mutation (Arg278Ser) associated with early onset Alzheimer's disease and spastic paraparesis.
    Raman A; Lin X; Suri M; Hewitt M; Constantinescu CS; Phillips MF
    J Neurol Sci; 2007 Sep; 260(1-2):78-82. PubMed ID: 17507029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.